Showing results (1971-1980 of 2,146) with videos related to

Sort By:
Pageof 215
BMJ Open|September 23, 2024
Cohort profile: the Swiss Mother and Child HIV Cohort Study (MoCHiV)Paolo Paioni, Murezi Capaul, Anja Brunner, et al.
Antioxidants & Redox Signaling|August 10, 2016
Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in MiceSara Vandenwijngaert, Melissa Swinnen, Ann-Sophie Walravens, et al.
Plos One|February 25, 2016
Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research StudyCharlène Insam, Marie Méan, Andreas Limacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2024
Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical TrialIgor Makhlin, Biniyam G Demissei, Ralph D'Agostino, et al.
Clinical Chemistry|February 26, 2003
Exploiting the enzymatic recognition of an unnatural base pair to develop a universal genetic analysis systemMichael J Moser, David J Marshall, Jennifer K Grenier, et al.
Circulation Research|December 2, 2006
Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shockFumito Ichinose, Emmanuel S Buys, Tomas G Neilan, et al.
European Heart Journal|May 24, 2006
Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injuryTomas G Neilan, Davinder S Jassal, Teresa M Perez-Sanz, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
First results of a national deployment of a fully automated central-line-associated bloodstream infection (CLABSI) surveillance system, Switzerland, 2022 to 2023Gaud Catho, Jason Toko, Loïc Fortchantre, et al.
The American Journal of Cardiology|March 5, 2011
Early detection and prediction of cardiotoxicity in chemotherapy-treated patientsHeloisa Sawaya, Igal A Sebag, Juan Carlos Plana, et al.
The Lancet. Neurology|May 3, 2017
Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trialEnrico Bertini, Eric Dessaud, Eugenio Mercuri, et al.
Pageof 215